Cite Filings / JSPR
Feed Companies Filings Check
Sign in

CIK 0001788028 · <br>Emerging growth company

Jasper Therapeutics, Inc.

Sign in to watch
Ticker
JSPR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
842984849
Phone
6505491400
Business address
2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
Former names
Amplitude Healthcare Acquisition Corp
Filings Insiders Search text
All 484 Financials 125 Shareholder Meetings 13 Executive Compensation 112 Insider Trading 158 Beneficial Ownership Interest 78 Business Combinations 112 Public Offerings 52 Mutual Funds and ETFs 9 Others 48
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-10-19
  3. PRE 14A Proxy Proxy Statement (Preliminary) 2026-10-09
  4. DEF 14A Proxy Proxy Statement 2026-09-04
  5. PRE 14A Proxy Proxy Statement (Preliminary) 2026-08-24
  6. DEF 14A Proxy Proxy Statement 2026-06-15
  7. DEF 14A Proxy Proxy Statement 2025-05-19
  8. DEF 14A Proxy Proxy Statement 2024-04-22
  9. DEF 14A Proxy Proxy Statement 2023-11-20
  10. PRE 14A Proxy Proxy Statement (Preliminary) 2023-11-09
  11. DEF 14A Proxy Proxy Statement 2023-04-21
  12. PRE 14A Proxy Proxy Statement (Preliminary) 2023-04-10
  13. DEF 14A Proxy Proxy Statement 2022-04-29
  14. DEF 14A Proxy Proxy Statement 2020-12-04

Page 1 of 1 · 13 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…